Asia Pacific Contrast Media Market is likely to be valued at USD 1.19 Billion by 2023
Asia Pacific Contrast Media Market By Procedure, By Type, By Application (Radiology, Interventional Radiology, & Interventional Cardiology) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)
(EMAILWIRE.COM, October 18, 2018 ) Overview:
Contrast is a chemical used to improve the contrast of fluids in the body during the medical image. The dye helps to improve the visibility of the blood vessels and the gastrointestinal tract. Contrast products are classified into two types that can be iodine contrast product and a gadolinium contrast product. When images are captured with contrast product, the color of the structures is changed in the body. This helps to improve the contrast between different parts of the body and can also differentiate different parts of the Human body that has similar compositions.
View sample and decide: https://www.marketdataforecast.com/market-reports/asia-pacific-contrast-media-market-3418/request-sample
Asia Pacific Contrast Media Market size was around USD 0.98 billion in 2018. It is expected to grow at a CAGR of 3.9% to reach USD 1.19 billion by 2023.
Drivers and Restraints:
Increasing aging population, rising demand for image-guided techniques, growing prevalence of chronic diseases, increased usage of X-ray, CT scan, angiography, and ultrasound imaging in healthcare facilities, and rising healthcare expenditure. In addition, introduction of innovative techniques, increasing investment for R&D activities, and advancement of technologies in medical sector is expected to drive the market growth. However, high risk of side effects and stringent government policies are expected to hinder the growth
To know more read: https://www.marketdataforecast.com/market-reports/asia-pacific-contrast-media-market-3418/
Geographic Segmentation
The Asia Pacific Contrast Media Market has geographically segmented into China, India, Japan, South Korea, and Australia. China and India are likely to increase the market because of the huge population. Also Asia Pacific is a largest growing segment.
Get your customized report: https://www.marketdataforecast.com/market-reports/asia-pacific-contrast-media-market-3418/customize-report
Major companies in the market are CMC Contrast AB (Sweden), Daiichi Sankyo (Japan), Bayer HealthCare (Germany), GE Healthcare (U.S.), Guerbet Group (France), Bracco Imaging S.p.A. (Italy) in 2015. Lantheus Medical Imaging (U.S.), nanoPET Pharma GmbH (Germany), and Subhra Pharma Private Limited (India).
Scope of the report:
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony,
Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Contrast is a chemical used to improve the contrast of fluids in the body during the medical image. The dye helps to improve the visibility of the blood vessels and the gastrointestinal tract. Contrast products are classified into two types that can be iodine contrast product and a gadolinium contrast product. When images are captured with contrast product, the color of the structures is changed in the body. This helps to improve the contrast between different parts of the body and can also differentiate different parts of the Human body that has similar compositions.
View sample and decide: https://www.marketdataforecast.com/market-reports/asia-pacific-contrast-media-market-3418/request-sample
Asia Pacific Contrast Media Market size was around USD 0.98 billion in 2018. It is expected to grow at a CAGR of 3.9% to reach USD 1.19 billion by 2023.
Drivers and Restraints:
Increasing aging population, rising demand for image-guided techniques, growing prevalence of chronic diseases, increased usage of X-ray, CT scan, angiography, and ultrasound imaging in healthcare facilities, and rising healthcare expenditure. In addition, introduction of innovative techniques, increasing investment for R&D activities, and advancement of technologies in medical sector is expected to drive the market growth. However, high risk of side effects and stringent government policies are expected to hinder the growth
To know more read: https://www.marketdataforecast.com/market-reports/asia-pacific-contrast-media-market-3418/
Geographic Segmentation
The Asia Pacific Contrast Media Market has geographically segmented into China, India, Japan, South Korea, and Australia. China and India are likely to increase the market because of the huge population. Also Asia Pacific is a largest growing segment.
Get your customized report: https://www.marketdataforecast.com/market-reports/asia-pacific-contrast-media-market-3418/customize-report
Major companies in the market are CMC Contrast AB (Sweden), Daiichi Sankyo (Japan), Bayer HealthCare (Germany), GE Healthcare (U.S.), Guerbet Group (France), Bracco Imaging S.p.A. (Italy) in 2015. Lantheus Medical Imaging (U.S.), nanoPET Pharma GmbH (Germany), and Subhra Pharma Private Limited (India).
Scope of the report:
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony,
Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results